# Polymyxin B

NDC: 0143-9461
Generic name: Polymyxin B Sulfate
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS, OPHTHALMIC
Marketing started: 20250930

FDA application: ANDA202766

## Active ingredients

- POLYMYXIN B SULFATE: 500000 [USP'U]/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0143-9461"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0143-9461
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2bf65f6-2763-4859-a665-ad5e6cde71ee